Medindia

X

FDA Commissioner Addresses Nation's Health Care Professionals on H1N1 Vaccine Safety

Saturday, January 16, 2010 Press Release J E 4
Advertisement


SILVER SPRING, Md., Jan. 15 FDA Commissioner Margaret A. Hamburg today sent a letter to America's health care professionals thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on safety monitoring of the 2009 H1N1 vaccines.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

"In November, I wrote to thank you for your efforts during the 2009 H1N1 influenza outbreak and to provide information about the development and FDA approval of the H1N1 vaccines," Hamburg wrote. "I mentioned our continuing robust efforts to monitor the safety of these vaccines and now would like to reassure you that, to date, the safety assessment is very encouraging.

"As a key part of our missions, the FDA, the Centers for Disease Control and Prevention, other agencies across the Department of Health and Human Services, and other parts of the federal government, including the Department of Defense and the Department of Veterans Affairs, have enhanced and expanded our vaccine safety monitoring systems to detect and quickly investigate any unexpected, rare, or serious adverse events. These additional systems enhance our ability to determine whether any adverse events can be attributed to H1N1 influenza vaccines. A detailed description of vaccine safety efforts is available online at www.flu.gov.

"According to the January 8, 2010 update of FDA and CDC vaccine safety monitoring activities, as of December 30, 2009 the total number of doses of H1N1 vaccines distributed was 99.3 million and the vast majority (94%) of adverse events reported to VAERS were classified as "non-serious" (e.g., soreness at the vaccine injection site). Weekly updates on FDA and CDC vaccine safety monitoring activities are available through the VAERS web site (http://vaers.hhs.gov/resources/h1n1update#top)."

The letter is online at:

http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm197733.htm

Media Inquires: Dick Thompson, Contacts: 301-796-7566 or 240-753-3049; dick.thompson@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA

SOURCE U.S. Food and Drug Administration
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
BioMed Realty Trust Announces Tax Treatment of 200...
S
dLife Connects Largest Online Diabetes Community t...